CIK: 0001608126 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 13, 2024
Total Value ($000): $352,286 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LBRDK | LIBERTY BROADBAND CORP | 1,994,510 | $109,339 | 31.0% | $62.73 | -22.9% | COM SER C | 530307305 |
| RVMD | REVOLUTION MEDICINES INC | 729,464 | $28,310 | 8.0% | $28.74 | +30.0% | COM | 76155X100 |
| ASND | ASCENDIS PHARMA A/S | 189,272 | $25,813 | 7.3% | $96.64 | — | SPONSORED ADR | 04351P101 |
| — | SPRINGWORKS THERAPEUTICS INC | 638,352 | $24,047 | 6.8% | $17.39 | — | COM | 85205L107 |
| ARGX | ARGENX SE | 54,028 | $23,234 | 6.6% | $396.43 | — | SPONSORED ADR | 04016X101 |
| SRPT | SAREPTA THERAPEUTICS INC | 132,835 | $20,988 | 6.0% | $116.29 | +10.5% | COM | 803607100 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 388,835 | $17,097 | 4.9% | $43.28 | -2.1% | CLASS A ORD | 61559X104 |
| ARVN | ARVINAS INC | 574,378 | $15,290 | 4.3% | $41.50 | -23.2% | COM | 04335A105 |
| ACAD | ACADIA PHARMACEUTICALS INC | 905,384 | $14,712 | 4.2% | $19.57 | -17.5% | COM | 004225108 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,776,728 | $14,605 | 4.1% | $15.68 | -57.1% | COM | 89422G107 |
| CYTK | CYTOKINETICS INC | 256,449 | $13,894 | 3.9% | $40.89 | +47.6% | COM NEW | 23282W605 |
| GLPG | GALAPAGOS NV | 542,762 | $13,450 | 3.8% | $44.34 | — | SPON ADR | 36315X101 |
| RLAY | RELAY THERAPEUTICS INC | 1,605,346 | $10,467 | 3.0% | $13.30 | -48.6% | COM | 75943R102 |
| PRTA | PROTHENA CORP PLC | 433,471 | $8,947 | 2.5% | $32.58 | -33.6% | SHS | G72800108 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 707,404 | $6,154 | 1.7% | $23.98 | -41.8% | COM NEW | 30233G209 |
| SLDB | SOLID BIOSCIENCES INC | 961,251 | $5,450 | 1.5% | $5.95 | +50.6% | COM NEW | 83422E204 |
| — | CHURCHILL CAPITAL CORP VII | 548,000 | $192 | 0.1% | $0.92 | — | *W EXP 02/29/202 | 17144M110 |
| MNYWW | MONEYHERO LIMITED | 895,000 | $72 | 0.0% | $0.12 | — | *W EXP 09/13/202 | G6202B119 |
| CNDAW | CONCORD ACQUISITION CORP II | 408,333 | $45 | 0.0% | $0.95 | — | *W EXP 99/99/999 | 20607U116 |
| IVCPW | SWIFTMERGE ACQUISITION CORP | 490,000 | $39 | 0.0% | $0.21 | — | *W EXP 12/13/202 | G63836111 |
| LSBWF | LAKESHORE BIOPHARMA CO LTD | 489,999 | $33 | 0.0% | $0.16 | — | *W EXP 03/15/202 | G9845F117 |
| CLDWW | CALIDI BIOTHERAPEUTICS INC | 655,200 | $28 | 0.0% | $0.50 | — | *W EXP 03/14/202 | 320703119 |
| CDAWF | COMPASS DIGITAL ACQUISITION CORP | 459,906 | $28 | 0.0% | $0.76 | — | *W EXP 09/29/202 | G2476C123 |
| — | MARBLEGATE ACQUISITION CORP | 735,000 | $27 | 0.0% | $0.50 | — | *W EXP 08/31/202 | 56608A113 |
| — | CALIDI BIOTHERAPEUTICS INC | 125,000 | $25 | 0.0% | $3.33 | — | COM NEW | 320703101 |